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Regulated cell death (RCD) encompasses diﬀerent active
forms of cell death ranging from apoptosis to necrosis or
autophagy that are governed by distinct and highly sophisti-
cated molecular pathways. An event intimately associated
with RCD and RCD-associated pathologies, such as neurode-
generative or proliferative disorders, is redox homeostasis. A
better understanding of how a cell responds to RCD induced
by oxidative stress will undoubtedly uncover novel adaptive
stress strategies, thereby providing more insights towards
pro- or anti-RCD therapies.
This special issue unites 7 reviews and 5 original research
articles. Various eukaryotic cell systems are discussed and
include yeast, pathogenic fungi, zebraﬁsh, and cancer cells.
To uncover the complex network of the diﬀerent and often
interwoven RCD pathways and their association with oxida-
tive stress, as well as for drug discovery purposes, lower
eukaryotic cell model systems, including the budding yeast
Saccharomyces cerevisiae, are used. In addition, due to the
high conservation of RCD-related cellular processes, yeast
can be used to study human pathologies caused by deviations
in RCD. Moreover, the analysis of cell death routes solely
present/induced in yeast and other fungi might point to
novel therapeutic strategies to combat fungal infections.
To set the scene, K. F. Cooper describes the interplay
between autophagy and apoptosis, thereby focusing in
particular on the role of reactive oxygen species (ROS) in
these processes. In addition, the molecular mechanisms
underlying the induction and execution of RCD upon diverse
types of stress and their association with oxidative stress have
been addressed. Natural RCD-inducing scenarios such as
ageing or disease have been considered as well as RCD induc-
tion upon challenge with external toxins. K. Mohammad
et al. contributed with a relevant and timely review to the
mechanisms of the liponecrotic mode of RCD induced by
exogenous palmitoleic acid in the yeast S. cerevisiae. This
review integrates liponecrotic RCD in diﬀerent RCD
scenarios, including age-related cell death modalities. In
this respect, M. R. Yeaman et al. also provided a review
on novel antifungal peptides that induce RCD in pathogenic
fungi. Given the increasing impact of fungal infections on
society due to the increasing emergence of resistance
development and the relatively small armoury of antifungal
compounds, antifungal agents that induce fungal cell death
via a novel mode of action are of high relevance. Moreover,
D. Wilkinson et al. contributed an original research article
demonstrating that spatio-temporal metabolic diﬀerentiation
within yeast colonies of diﬀerent ages exists. They based their
research on a comprehensive transcriptomic analysis and
found that crucial metabolic reprogramming events arise
during colony ageing, thereby supporting a role for mito-
chondria in this diﬀerentiation process. D. Wilkinson et al.
also provided a review on the relevance of long noncoding
RNAs (lncRNA) in diﬀerentiated subpopulations of yeast
colonies and bioﬁlms. Diﬀerent cell types diﬀer in their
Hindawi
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 2480462, 2 pages
https://doi.org/10.1155/2018/2480462
complements of lncRNA, which target diverse functional
categories of genes in diﬀerent cell subpopulations and
speciﬁc colony types. These contributions highlight how
S. cerevisiae colonies have become an excellent model for
studying various aspects of microbial multicellularity,
including cell diﬀerentiation and communication. In an
original contribution, R. Zadrag-Tecza et al. used S. cerevisiae
to study the impact of increased cell size on replicative
ageing. An analysis of yeast cells harbouring diﬀering
genome copy numbers, ranging from haploid to tetraploid,
provides evidence for a correlation between an increase in
cell volume achieved via additional genome copies and the
reproductive as well as the postreproductive lifespan.
Besides that, analysis of adaptive stress strategies or
tolerance mechanisms elicited by diﬀerent organisms under
RCD stress or oxidative stress in general is of great interest.
This knowledge can be exploited to develop eﬀective combi-
nation therapy. In this respect, K. Vriens et al. contributed a
study on the tolerance mechanisms that are induced by
amphotericin B in yeast and in the human pathogen Candida
albicans using a microﬂuidics platform. They show that the
fungicidal action of amphotericin B can be increased by
inhibiting the nitric oxide-dependent tolerance pathway via
the NO synthase inhibitor L-NAME. This resulted in a fungi-
cidal combination treatment based on AMB and L-NAME.
Redox homeostasis and cell death were also addressed
in diﬀerent diseases and models with therapeutic aims.
M. Cobbaut and J. Van Lint discussed the role of protein
kinase D (PKD) isoforms as regulators of the oxidative
stress response. They highlight the diﬀerential activation
of the speciﬁc PKD isoforms upon increased oxidative
burden and the signaling pathways mediating their down-
stream eﬀects as well as their isoform-speciﬁc characteristics.
H. Gu et al. provided a review on the occurrence of radiore-
sistance in gastric cancer, which is one of the primary causes
responsible for therapeutic failure and recurrence of cancer
and linked to ROS. In an original contribution, A. A. Kulk-
arni et al. used a transgenic nitroreductase-expressing zebra-
ﬁsh model treated with the prodrug metronidazole to
demonstrate that ROS can be generated in a beta cell-
speciﬁc manner. This hybrid chemical/genetic approach
allows monitoring of ROS generation in beta cells in situ,
and its manipulation, for instance by antioxidants, is shown
to be protective for beta cells under conditions of elevated
ROS production.
P. Davalli et al. contributed with a review on the DNA
damage response (DDR) as a target for oxidative-based
cancer therapy. DDR is deeply aﬀected and sensitive to redox
homeostasis since ROS regulate several enzymes of this
repair pathway. The authors reviewed mechanisms contrib-
uting to ROS homeostasis, the ROS-sensitive proteins in
DDR, and how DDR could be targeted in cancer therapy by
using DDR inhibitors combined with ROS-inducing drugs.
In an original article, S. V. Kostyuk et al. analysed the
response of several human cell types to cell-free DNA
diﬀering in GC content and grade of oxidation. They provide
insights into the diﬀerent expression patterns of the tran-
scription factors NF-κB and NRF2 following treatment
with distinct DNA species. While oxidized cell-free DNA
elicited a very fast and intense inﬂammatory response,
often leading to apoptosis, nonoxidized species rich in GC
rather triggered a weaker response, promoting cell survival
possibly via hormesis.
In conclusion, this special issue will provide more
insights into RCD and into tolerance mechanisms elicited
in cells experiencing RCD. Such information can prove
very valuable in designing novel (combinatorial) pro- or
anti-RCD therapies.
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